An increasing body of evidence suggests that TMEM176A can inhibit tumor cell growth and migration by constraining extracellular signal-regulated kinase (ERK) signal transduction in lung, pancreatic and liver cancer (39–41). Here, TMEM176A is linked to neoplasm.